Skip to content
The Nexus
DossierENTITY

CREATE Medicines

Coverage of CREATE Medicines in the Nexus archive.

Earliest in view: May 14 · 11:00 UTCMost recent: May 14 · 14:14 UTC
Co-mentioned in this coverage
BeOneorganization1FDAorganization1Trump administrationorganization1CAR-Ttopic1Siddhartha Mukherjeeperson1Myeloid Therapeuticsorganization1Newpath Partnersorganization1ARCH Venture Partnersorganization1Hatteras Venture Partnersorganization1
Recent coverage
  • HEALTHMay 14 · 14:14 UTCSTAT NEWS
    STAT+: BeOne wins FDA approval in lymphoma race

    BeOne wins FDA approval in lymphoma race, while Biotech's cell therapy boom expands beyond cancer and CREATE Medicines raises $122 million to advance its in vivo CAR-T for autoimmune disease. The Trump administration is searching for a new FDA commissioner. BeOne's approval marks a significant development in the treatment of lymphoma.

  • HEALTHMay 14 · 11:00 UTCSTAT NEWS
    STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million

    CREATE Medicines, a biotech company, raises $122 million to develop CAR-T therapies, expanding its pipeline and researching autoimmune diseases. The company was cofounded by Siddhartha Mukherjee and recently rebranded from Myeloid Therapeutics. This funding will propel the company's first CAR-T candidates through human trials.

CREATE Medicines · Dossier · The Nexus